UnknownNCT06358014
Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen
Medication studyUp to age 70China
Understand this study
Who could participate?
Listed age limits: up to 70 years.
- Listed locations
- BeijingSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 12, 2023
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 40
- Sponsor
- Xiao Wang
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Locations
- China
- Age range
- Up to 70 Years
- Official registry ID
- NCT06358014
- Official title
Show the full official title
Beijing Anding Hospital Affiliated to Capital Medical University
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Beijing
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Xiao Wang.
Does this study involve medication?
Yes. The study involves medication, including Fematon (estradiol/estradiol-norethindrone acetate combination tablet package)+SSRIs and SSRIs.
Who can participate?
Listed age limits: up to 70 years.
